China News
-
John Crowley is Charles River's CAO
China | Influencers | By BioSpectrum Bureau | 1 Comment | 27 Sep, 2013
Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate contro...Read more
-
Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...Read more
-
Innovative way to meet the global HSA requirement
China | News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2012
Human serum albumin (HSA), a blood protein that is widely used in drug and vaccine production, is in high demand around ...Read more
-
BGI-Shenzhen extends tender offer for Complete Genomics
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: BGI-Shenzhen (BGI) announced that it, through its wholly owned subsidiary Beta Acquisition, has extended its...Read more
-
China Botanic gets warning from NYSE
China | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2013
Singapore: China Botanic Pharmaceutical (formerly Renhuang Pharmaceuticals) received a warning letter from the NYSE MKT...Read more
-
New strategies drive growth in Yunnan Baiyao
China | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Yunnan Baiyao made new strategies for 2011 and the year recorded relocation, expansion of the company's business develop...Read more
-
Biostar signs another $3 mn military contract within a month
China | News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2012
Singapore: China-based Biostar Pharmaceuticals signed a one-year agreement, valued at approximately $3.0 million, to man...Read more
-
Chinese to get first-ever oral rotavirus vaccine
China | News | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2013
Singapore: The not-for-profit organization, International Medica Foundation, that works towards the development of a saf...Read more
-
Xiangxue Pharma acquires rights for Kinex KX02
China | News | By BioSpectrum Bureau | 0 Comment | 22 May, 2012
Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceut...Read more
-
Chinese, Hong Kong scientists map H7N9 risk infection
China | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2013
Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production ...Read more
-
Mr George Baeder, Quintiles: Companies will fail to leverage on what China has to offer in 2013
China | Opinion | By BioSpectrum Bureau | 3 Comment | 25 Dec, 2012
China's role in the global drug industry will fundamentally change; most companies will fail to capitalize on this oppor...Read more
-
Takeda's diabetes drug gets Chinese FDA nod
China | Regulatory | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has ...Read more
-
Guangzhou records a whopping growth of over 50%
China | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognize...Read more
-
What bioscience trends do the industry leaders predict for 2013?
China | Analysis | By BioSpectrum Bureau | 0 Comment | 03 Jan, 2013
The bioscience industry is about to step into 2013 and the year is predicted to unfold with new opportunities and trends...Read more
-
Pfizer animal health firm to make pig vaccines
China | Regulatory | By BioSpectrum Bureau | 0 Comment | 06 Aug, 2013
Singapore: Zoetis, which is the animal health business of Pfizer, received approval by Chinese Ministry of Agriculture f...Read more
-
Joan Yan is Marken's GM in China
China | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2013
Singapore: Global clinical supply chain solutions provider, Marken, appointed Ms Joan Yan as its new general manager for...Read more
-
Top pharma deals in the last 5 years in APAC
China | Opinion | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2012
The number of mergers and acquisitions (M&A) that have been made over the past two years have almost returned to pre...Read more
-
What are the key mergers & acquisitions of Q1 2013?
China | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The...Read more
